The companies in question, Dr. Reddy’s Laboratories, Sun Pharma and Zydus Pharmaceuticals, are recalling seizure treatments, ...

Hyderabad: Dr Reddy’s Laboratories Ltd., is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride ...

The potential risks include hypersensitivity reactions, liver injury, hematological toxicity, drowsiness, dizziness, ...

Dr. Reddy's recalls Levetiracetam infusion bags in the U.S. due to mislabeling, posing risk of serious adverse effects.

The mislabeling poses a significant health risk, as patients receiving the drug could inadvertently be administered double ...

Dr. Reddys Laboratories is recalling a batch of Levetiracetam injection bags in the U.S. due to incorrect labeling, which ...

UCB has been able to build off of Keppra, a broad-spectrum anti-epileptic drug, or AED, that was initially approved in the US in 1999. In the US and Europe, Keppra lost its patent exclusivity in ...

In September, Akeso, a little-known Chinese biotech company founded nearly a decade ago shook up the biotech sector with its new lung cancer drug. Ivonescimab, the new drug, was found in a trial ...

The research team from the School of Pharmacy at Waterloo looked specifically at Levetiracetam. It is a drug commonly prescribed long term for women with epilepsy, yet there was minimal data on ...

A new mathematical model developed at the University of Waterloo can determine a baby’s overall drug exposure when their mother is taking medication. This is the first study to include drug transfer ...

Generic drugs have saved billions of dollars and benefited countless lives by making existing medicines more affordable. But a new study finds these drug copies may not all be created equal. Despite ...

A new study reveals that generic drugs manufactured in India have a higher association with severe adverse events such as hospitalization, disability, and death compared to those made in the U.S ...